Egetis Therapeutics AB (publ) (OM:EGTX) Commented on Market Rumors. Egetis Has Ongoing Discussions with Certain External Parties Regarding A Potential Acquisition of Company. There Can Be No Certainty That A Public Take-Over Offer Will Be Made, Nor as to Terms of Any Such Offer.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
7.17 SEK | +16.97% | +17.35% | +28.49% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+28.49% | 166M | |
+5.33% | 111B | |
+12.11% | 106B | |
-12.56% | 22.24B | |
-3.46% | 21.25B | |
-5.61% | 18.97B | |
-35.21% | 18.52B | |
-10.86% | 16.81B | |
+37.57% | 12.54B | |
-26.24% | 8.09B |
- Stock Market
- Equities
- EGTX Stock
- News Egetis Therapeutics AB
- Egetis Comments on M&A Rumors